BVS
Bioventus Inc
NASDAQ: BVS · HEALTHCARE · MEDICAL DEVICES
$9.87
+2.07% today
Updated 2026-04-30
Market cap
$682.47M
P/E ratio
30.58
P/S ratio
1.20x
EPS (TTM)
$0.33
Dividend yield
—
52W range
$6 – $11
Volume
0.4M
Bioventus Inc (BVS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+18.0%
Last 4 quarters
Revenue YoY growth
+2.8%
Most recent quarter
EPS YoY growth
+60.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.5%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+12.5%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $0.24 | +17.5% | $8.87 | $8.92 | +0.6% |
| 2025-11-04 | $0.15 | +36.4% | $6.56 | $7.38 | +12.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.20 | $0.24 | +17.5% | $157.90M | +2.8% |
| 2025-09-30 | $0.11 | $0.15 | +36.4% | $138.65M | -0.2% |
| 2025-06-30 | $0.21 | $0.21 | +0.0% | $147.66M | -2.4% |
| 2025-03-31 | $0.02 | $-0.04 | -275.0% | $123.88M | -4.3% |
| 2024-12-31 | $0.09 | $0.15 | +76.5% | $153.64M | +13.5% |
| 2024-09-30 | $0.03 | $0.06 | +100.0% | $138.96M | +15.0% |
| 2024-06-30 | $0.07 | $0.19 | +171.4% | $151.22M | +10.3% |
| 2024-03-31 | $-0.07 | $0.07 | +200.0% | $129.46M | +8.7% |
| 2023-12-31 | $0.02 | $0.07 | +250.0% | $135.42M | — |
| 2023-09-30 | $-0.02 | $0.05 | +350.0% | $120.79M | — |
| 2023-06-30 | $0.03 | $0.14 | +366.7% | $137.07M | — |
| 2023-03-31 | $-0.15 | $-0.26 | -73.3% | $119.06M | — |
| 2022-12-31 | $0.05 | $-0.06 | -220.0% | — | — |
Frequently asked questions
Has Bioventus Inc beaten earnings estimates?
Bioventus Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +18.0% over the last 3 quarters.
How does BVS stock react to earnings?
BVS stock has moved an average of +6.5% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Bioventus Inc's revenue growth rate?
Bioventus Inc reported year-over-year revenue growth of +2.8% in its most recent quarter, with EPS growing +60.0% year-over-year.